Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.46 |
| ▸ | ADH1B | P00325 | 1/20 | 0.46 |
| ▸ | ADH1C | P00326 | 1/20 | 0.46 |
| ▸ | ADH1A | P07327 | 1/20 | 0.46 |
| ▸ | ADH7 | P40394 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL445629 | 0.85 | MAPT (0.48) | IDO1MEN1KMT2ATHRBTDP1 | |
| SCHEMBL11779489 | 0.84 | APP (0.46) | IDO1MEN1KMT2ATHRBTDP1 | |
| SCHEMBL447667 | 0.82 | IDO1 (0.46) | IDO1MEN1KMT2ATHRBTDP1 | |
| SCHEMBL10599065 | 0.82 | IDO1 (0.46) | IDO1MEN1KMT2ATHRBTDP1 | |
| SCHEMBL6014578 | 0.80 | MAPT (0.44) | IDO1MEN1KMT2ATHRBTDP1 | |
| SCHEMBL3399019 | 0.79 | IDO1 (0.48) | IDO1MEN1KMT2ATHRBTDP1 | |
| SCHEMBL581278 | 0.79 | MAPT (0.52) | IDO1MEN1KMT2ATHRBTDP1 | |
| SCHEMBL2701017 | 0.79 | IDO1 (0.48) | IDO1MEN1KMT2ATHRBTDP1 | |
| SCHEMBL27353 | 0.79 | CA2 (0.48) | IDO1MEN1KMT2ATHRBTDP1 | |
| SCHEMBL2549267 | 0.79 | ALOX12 (0.48) | IDO1MEN1KMT2ATHRBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090143475-A1 | BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS | DEY, L.P. (US) | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143475-A1 | BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS | ADRB2, ADRB3, ADRB1 | IDO1 1639/4885MEN1 2989/4885KMT2A 3591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.